Braavos Capital
Investor profile
Venture capital
Braavos Capital has backed 8 European tech companies across 8 funding rounds between 2021 and 2025, joining rounds totalling €318M. Most active in Healthtech and AI. Data as of Nov 2026.
Also recorded as: Braavos Investment Advisers
Deals
8
distinct rounds
Companies
8
backed
Active span
2021–2025
5 yrs
Total round €
€318M
sum of rounds joined
Deals by year
distinct rounds / yearBraavos Capital — deals by year — interactive chart.
Data table
| Braavos Capital — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsBraavos Capital — top sectors — interactive chart.
Data table
| Braavos Capital — top sectors | |
|---|---|
| Healthtech | 2 |
| AI | 1 |
| Cleantech | 1 |
| Energy | 1 |
| Hardware | 1 |
| Cybersecurity | 1 |
| Semiconductors | 1 |
Stages
by dealsBraavos Capital — stages — interactive chart.
Data table
| Braavos Capital — stages | |
|---|---|
| Series A | 5 |
| Series C | 2 |
| Series B | 1 |
Countries
by dealsBraavos Capital — countries — interactive chart.
Data table
| Braavos Capital — countries | |
|---|---|
| UK | 8 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Oxford Science Enterprises4
- Lansdowne Partners2
- 2xN1
- Addition1
- Applied Ventures1
- Aramco Ventures1
- Axial1
- Cambridge Innovation Capital1
- Chevron Technology Ventures1
- Clean Energy Ventures1
- Doral Energy-Tech Ventures1
- Eni Next1
- F-Prime Capital1
- General Catalyst1
- Hermann Hauser1
- Hostplus1
- ICM HPQC Fund1
- IP Group1
- Jalal Bagherli1
- Khosla Ventures1
- Kiko Ventures (IP Group)1
- Legal & General1
- LLC1
- M&G Investments1
- OrbiMed1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Osler Diagnostics | UK | 1 | €85M |
| Charm Therapeutics | UK | 1 | €47M |
| First Light Fusion | UK | 1 | €40M |
| PQShield | UK | 1 | €35M |
| Oxford Ionics | UK | 1 | €34M |
| Salience Labs | UK | 1 | €29M |
| SpyBiotech | UK | 1 | €27M |
| Oxccu | UK | 1 | €21M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Osler Diagnostics | Series C | €85M | 2022-11 |
| Charm Therapeutics | Series A | €47M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| PQShield | Series B | €35M | 2024-06 |
| Oxford Ionics | Series A | €34M | 2023-01 |
| Salience Labs | Series A | €29M | 2025-02 |
| SpyBiotech | Series A | €27M | 2021-02 |
| Oxccu | Series A | €21M | 2023-06 |